Early Cancer Detection in Malaysia: Why Affordable Access Matters
Early detection and affordable access go hand in hand. For certain cancers, screening can identify possible problems before symptoms appear, but an abnormal result does not necessarily mean cancer. Early detection is most useful when people can access appropriate care, understand their results and receive timely follow-up when needed. [7]
In Malaysia, GLOBOCAN 2024 estimated 54,586 new cancer cases. Colorectal cancer was the second most commonly diagnosed cancer, with 7,693 estimated new cases in 2024. [1]
When you feel well, cancer screening can be easy to postpone. Work, family and everyday responsibilities often feel more urgent than a test for a condition that may not be causing any obvious symptoms.
Screening matters because certain cancers can be detected before symptoms appear, even in people who feel healthy. For eligible individuals, screening may help identify possible signs of certain cancers, while seeking medical advice promptly when symptoms arise is equally important. Early detection, followed by timely diagnosis and appropriate treatment, can improve health outcomes. [6, 7]
Why does early cancer detection matter in Malaysia?
Cancer is a significant health concern in Malaysia. GLOBOCAN 2024 estimated 54,586 new cancer cases in the country in 2024. Colorectal cancer accounted for 7,693 cases, or 14.1% of the total, making it the second most commonly diagnosed cancer. [1]
Malaysia also continues to see many cancers diagnosed at a later stage. The Malaysia National Cancer Registry Report 2017-2021 reported that 74.9% of colorectal cancers in men and 74.4% in women were diagnosed at Stage III or IV. For prostate cancer, 67.0% of cases in men were diagnosed at Stage III or IV during the same period. [2]
These figures do not necessarily mean that every cancer requires the same screening approach. Instead, they highlight the importance of understanding which screening tests may be appropriate, recognising possible cancer symptoms and seeking timely medical advice when needed. The aim is not to create fear. It is to help people make informed decisions about their health. [7]
Why is affordable access part of early detection?
Awareness is only the first step. A person may know screening is important and still delay due to matters such as cost, distance, uncertainty about the test, or concern about what happens after an abnormal result. [7]
The World Health Organization describes access barriers as part of the early-diagnosis problem. Effective early-detection pathways may need more than a test: people need easy access to healthcare professionals, diagnostic services and timely referral to appropriate treatment. [7]
Ribbon of Hope aims to bridge this gap by connecting people to the support, screening services and care they need through community partnerships. The role of a community pharmacy is not to replace doctors or hospitals. It is to make the first step more approachable and to help connect people to the appropriate next level of care. [10, 11]
What is iFOBT and how does colorectal cancer screening work?
The immunochemical faecal occult blood test, or iFOBT, is a stool-based screening test that looks for small amounts of blood that may not be visible to the eye. It is non-invasive and can be completed using a stool sample. [4, 6]
Screening and follow-up at a glance
| Test / procedure | What it does | What an abnormal result means | Typical next step |
|---|---|---|---|
| iFOBT | Detects hidden blood in a stool sample. | A positive result does not confirm colorectal cancer. Blood in stool may have several possible causes. | Medical assessment, commonly including colonoscopy. |
| Colonoscopy | Allows a healthcare professional to examine the inside of the colon and rectum. | Findings may include polyps, bleeding sources or suspicious tissue that needs further testing. | Clinical management depends on the findings; tissue may be sampled or polyps removed. |
| PSA blood test | Measures the level of prostate-specific antigen in the blood. | A raised PSA does not by itself confirm prostate cancer; non-cancerous conditions can also raise PSA. | Repeat testing or further medical review is required, which may include examination, imaging or biopsy. |
Sources: Malaysian Ministry of Health colorectal cancer guidance and NCI PSA information. [4, 6, 8]
What does a positive iFOBT result mean?
A positive iFOBT means blood was detected in the sample. It does not necessarily mean you have colorectal cancer. Blood in the stool can be associated with haemorrhoids, polyps, inflammation and other bowel conditions as well as cancer. The important next step is further medical assessment. Malaysian clinical guidelines recommend early colonoscopy after a positive iFOBT result. [3, 4]
What does a negative iFOBT result mean?
A negative result means the test did not detect blood in that particular sample. It does not completely rule out every bowel condition or guarantee that cancer is absent. For average-risk people who remain eligible for screening, Malaysian guidance recommends repeating iFOBT yearly following a negative result. Anyone experiencing concerning bowel symptoms should seek medical assessment even if a screening test is negative. [4, 6]
At what age should Malaysians consider colorectal cancer screening?
For average-risk adults, the Ministry of Health's clinical practice guideline recommends colorectal cancer screening from age 50 to 75, with iFOBT as the preferred screening method. If the iFOBT is negative, yearly testing is recommended; if it is positive, colonoscopy is needed for further assessment. [4]
People with a family history of colorectal cancer or other risk factors may require screening at an earlier age or a different screening approach. Screening recommendations should therefore take individual risk factors into account, rather than age alone. [4, 6]
Colorectal cancer screening recommendations may vary between countries. For example, the US Preventive Services Task Force (USPSTF) recommends screening for average-risk adults aged 45 to 75, while Malaysia's Ministry of Health recommends screening for average-risk adults aged 50 to 75, with iFOBT as the preferred screening method. [4, 12]
To support colorectal cancer awareness and improve access to screening, BIG CARiNG Group and CORUM have collaborated on a nationwide initiative involving eligible Malaysians aged 45 to 75. [10]
Screening recommendations also depend on individual risk factors. People with a family history of colorectal cancer or other higher-risk factors may require screening at an earlier age or through a different approach. A healthcare professional can help assess individual risk and discuss appropriate screening options. [4, 6]
How does Ribbon of Hope make iFOBT screening more accessible?
Through its collaboration with the Colorectal Cancer Survivorship Society Malaysia (CORUM), BIG CARiNG Group is expanding access to iFOBT self-test kits through selected community pharmacies and outreach activities. The partnership announced in March 2026 aims to reach 10,000 eligible individuals and make screening more accessible for people aged 45 to 75. [10]
Eligible participants can obtain an iFOBT self-test kit for RM5 through participating BIG Pharmacy and CARiNG Pharmacy outlets, with the RM5 reimbursable after the test result is submitted. Programme terms, eligibility and participating outlets may change. Interested participants are encouraged to check with their nearest participating pharmacy for the latest programme details and eligibility requirements.
The value of the initiative is not only the lower cost. Pharmacists can explain how to use the kit and advise what to do if the result needs medical follow-up. That connection between screening and the next step is essential: a screening test only becomes useful when an abnormal result is acted on. [7, 10]
What should men know about PSA screening and Project Blue Dot?
A prostate-specific antigen, or PSA, test is a blood test that measures the level of PSA in the blood. PSA levels may be elevated in men with prostate cancer, but they can also increase due to non-cancerous conditions, such as an enlarged prostate or prostate inflammation. An elevated PSA result does not necessarily mean cancer, and further medical assessment may be needed to determine the cause. [8]
Project Blue Dot is a prostate cancer awareness and screening initiative led by the Rotary Club of Kuala Lumpur DiRaja with the National Cancer Society Malaysia (NCSM) and BIG CARiNG Group. Its nationwide phase offers initial PSA screening at selected pharmacy outlets and community sites, with priority for men aged 45 and above, particularly B40 and higher-risk groups. [11]
If you are considering a PSA test, you may use the screening opportunity as a starting point for an informed conversation with a healthcare professional to better understand your health status. [8, 9]
Why do community pharmacies matter in cancer screening?
Healthcare does not begin and end in a hospital. For many people, a community pharmacy is already a familiar place to collect medicines, ask health questions and speak with a healthcare professional.
That familiarity can help address practical barriers at the first step: not knowing where to go, uncertainty about how a test works, or hesitation about cost. Community screening initiatives should also be linked to clear pathways for follow-up, referral and diagnostic care when needed. [7, 10, 11]
Screening is not about expecting something to be wrong. It is about understanding which tests may be appropriate for you, what the results mean and when further medical assessment may be needed. [7]
What bowel symptoms should prompt medical assessment?
Screening is designed for people who may not have symptoms. If you do have persistent or unusual bowel-related symptoms, seek medical advice rather than waiting for routine screening. [6, 7]
- Blood in the stool or rectal bleeding
- A persistent change in bowel habits, such as ongoing diarrhoea, constipation or a change in stool pattern
- Persistent abdominal discomfort or pain
- Unexplained weight loss
- Unexplained tiredness or weakness
- A feeling that your bowel does not empty completely
These symptoms can have several causes and do not necessarily indicate cancer. They should be assessed by a doctor if they are persistent, unexplained or worsening. [4, 6]
Speak with a CARiNG pharmacist
If you are unsure how an iFOBT kit works, whether a community screening programme may apply to you, or what follow-up is needed after a screening result, a CARiNG pharmacist can help explain the next step. [10]
For symptoms, an abnormal screening result or concerns about cancer risk, the pharmacist can also advise when medical assessment is needed. [7]
Find your nearest CARiNG Pharmacy →Medical disclaimer: This article is for general health education and does not replace medical advice, diagnosis or treatment. Screening recommendations depend on age, symptoms, family history, personal risk and the specific cancer. A positive screening result is not a cancer diagnosis, and a negative result does not rule out all diseases. Seek medical advice if you have symptoms, an abnormal result or concerns about your personal risk.
Frequently asked questions about cancer screening in Malaysia
I feel perfectly healthy. Do I still need cancer screening?
Possibly, depending on your age, personal risk factors and the type of cancer. Screening aims to detect certain cancers or precancerous changes before symptoms appear. For colorectal cancer, Malaysia's Ministry of Health recommends screening for average-risk adults aged 50 to 75, with iFOBT as the preferred screening method. Some international guidelines, such as those from the US Preventive Services Task Force (USPSTF), recommend starting colorectal cancer screening at age 45. [4, 6, 7, 12]
What age should I start colorectal cancer screening in Malaysia?
For average-risk adults, the U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer screening from age 45 to 75. On the other hand, Malaysia's Ministry of Health recommends colorectal cancer screening from ages 50 to 75, with yearly iFOBT if the result is negative. People with family history or other higher-risk factors may need a different approach. Some community programmes have different eligibility criteria, so ask a healthcare professional what applies to you. [4, 6, 10, 12]
Is iFOBT the same as colonoscopy?
No. iFOBT is a stool-based screening test that looks for hidden blood in the stool, which can be the early sign of colorectal cancer. Colonoscopy is a procedure that allows a healthcare professional to examine the inside of the colon and rectum. A positive iFOBT usually needs further medical assessment, commonly including colonoscopy. [4]
Does a positive iFOBT result mean I have colorectal cancer?
No. A positive result means blood was found in the sample. Several conditions can cause bleeding. The result needs follow-up so a healthcare professional can determine the cause. [4]
Can a negative iFOBT rule out colorectal cancer?
No. A negative iFOBT result means that blood was not detected in the stool sample tested. However, it does not completely rule out colorectal cancer. Continue screening at the recommended interval (yearly) if you remain eligible. However, do seek medical advice if you experience persistent or concerning symptoms even if your iFOBT screening result is negative. [4, 6]
What is a PSA test, and does a high PSA mean prostate cancer?
A PSA test measures prostate-specific antigen in the blood. A high PSA can occur with prostate cancer, but it can also be caused by non-cancerous conditions such as benign prostate enlargement or prostatitis. An elevated PSA result does not necessarily indicate prostate cancer, and further medical assessment may be needed to determine the cause. [8]
View references 12 sources
- International Agency for Research on Cancer. Malaysia: GLOBOCAN 2024 fact sheet. Lyon: International Agency for Research on Cancer; 2026. Accessed 1 October 2026. Source
- Ministry of Health Malaysia. Summary of the Malaysia National Cancer Registry Report 2017-2021. Putrajaya: National Cancer Institute; 2024. Accessed 1 October 2026. Source
- CodeBlue. Colorectal cancer awareness in Malaysia: screenings, recovery and treatment options. Galen Centre for Health and Social Policy; 16 March 2023. Accessed 1 October 2026. Source
- Ministry of Health Malaysia. Management of Colorectal Carcinoma. Clinical Practice Guidelines. Putrajaya: Malaysia Health Technology Assessment Section, Medical Development Division; 2017. Accessed 1 October 2026. Source
- Ministry of Health Malaysia. National Strategic Plan for Colorectal Cancer 2021-2025. Putrajaya: Non-Communicable Disease Section, Disease Control Division; 2021. Accessed 1 October 2026. Source
- Ministry of Health Malaysia. Early Detection of Common Cancers and Referral Pathways Module for Health Care Providers. 1st Revision 2020; revised publication 2022. Accessed 1 October 2026. Source
- World Health Organization. Guide to Cancer Early Diagnosis. Geneva: WHO; 2017. Accessed 1 October 2026. Source
- National Cancer Institute. Prostate-Specific Antigen (PSA) Test. National Institutes of Health. Accessed 1 October 2026. Source
- Ministry of Health Malaysia. Prostate Cancer Screening. Health Technology Assessment; 2011. Accessed 1 October 2026. Source
- BIG CARiNG Group. BIG CARING Group and CORUM Launch Nationwide Initiative to Reach 10,000 Malaysians with Colorectal Cancer Screening. 31 March 2026. Accessed 1 October 2026. Source
- BIG CARiNG Group. Project Blue Dot Goes Nationwide with Expanded Partnership of Rotary Club of KL DiRaja, NCSM and BIG CARiNG Group at World Cancer Day 2026. 6 February 2026. Accessed 1 October 2026. Source
- US Preventive Services Task Force. Colorectal Cancer: Screening. 18 May 2021. Accessed 19 October 2026. Source
Latest Health Info
Early Cancer Detection in Malaysia: Why Affordable Access Matters
The short answer Early detection and affordable access go hand in hand. For certain cancers, screening can identify possible problems ...
Nutrition in Pregnancy: Fuelling Two Lives for a Healthy Future
The short answer Good nutrition during pregnancy means eating a varied, nutrient-dense diet and paying special attention to nutrients such ...
Glow Inside and Out: Key Tips for Women’s Health and Healthy Skin
Quick answer Healthy skin is supported by everyday habits first: a balanced diet, adequate sleep, regular physical activity, gentle skincare ...